Esperanza Sanchez-Martin
Pamplona, NC 00369, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Immune biomarkers of increased infection risk in multiple myeloma.
Journal: Blood
Published: September 22, 2025
Immune biomarkers of increased infection risk in multiple myeloma.
Journal: Blood
Published: September 22, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).
Journal: Research square
Published: June 12, 2025
Enhanced dynamic risk stratification of smoldering multiple myeloma.
Journal: Nature medicine
Published: May 19, 2025
A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies.
Journal: British journal of haematology
Published: July 15, 2024
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19.
Journal: Blood cancer journal
Published: March 26, 2024
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.
Journal: Blood advances
Published: March 20, 2024
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 17, 2022
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.
Journal: Blood cancer journal
Published: August 23, 2021
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
Journal: Frontiers in immunology
Published: January 26, 2021
Immunologic characterization of COVID-19 patients with hematological cancer.
Journal: Haematologica
Published: August 14, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026